Insider NameBuy/SellCompany NameTickerAmountShares Change
Mar 18, 2024Mar 19, 2024Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$5.04$47,204-4.63%
Jul 03, 2023Jul 06, 2023Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$25.04$42,593-2.08%
Jun 01, 2023Jun 05, 2023Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$30.64$98,070-3.81%
May 15, 2023May 17, 2023Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$34.55$739,338-20.30%
May 01, 2023May 02, 2023Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$31.7$101,472-4.83%
Apr 03, 2023Apr 04, 2023Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$32.15$102,912-4.61%
Mar 09, 2023Mar 10, 2023Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$31.59$584,884-20.18%
Mar 01, 2023Mar 03, 2023Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$33.5$107,234-6.09%
Feb 01, 2023Feb 03, 2023Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$34.6$110,755-5.53%
Jan 20, 2023Jan 23, 2023Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$31$31,000-1.70%
Jan 09, 2023Jan 11, 2023Schilke Tobin
CFO
SellRevance Therapeutics, Inc.RVNC$27.16$100,525-5.91%
Jun 26, 2018Jun 28, 2018Schilke Tobin
CFO
SellAchaogen IncAKAO$9.59$2,858-0.62%
Jun 11, 2018Jun 13, 2018Schilke Tobin
CFO
SellAchaogen IncAKAO$11.95$24,940-4.24%
Feb 21, 2018Feb 24, 2018Schilke Tobin
CFO
SellAchaogen IncAKAO$10.67$11,822-2.68%
Jun 12, 2017Jun 14, 2017Schilke Tobin
CFO
SellAchaogen IncAKAO$21.53$44,481-4.90%
Jan 26, 2017Jan 31, 2017Schilke Tobin
CFO
SellAchaogen IncAKAO$16.78$16,025-3.54%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.